Sorry, you need to enable JavaScript to visit this website.
Skip to main content

All materials and content available on the website are of strictly non-promotional nature and only intended for healthcare professionals (HCPs) practicing in Europe. Kindly note that materials and content are not intended for any specific country and approval conditions for products may vary from country to country. Before prescribing any product, always refer to the approved label in the relevant country and/or the Summary of Product Characteristics.

  • February 18, 2022
  • CKD-MBD and SHPT

Where are we now? Emerging opportunities and challenges in the management of SHPT in patients with ND-CKD

Explore the science
  • February 18, 2022
  • CKD-MBD and SHPT

The rationale for raising the 25(OH)D target to >50 ng/mL in patients with ND-CKD

Explore the science
  • February 18, 2022
  • Hyperkalemia

KDIGO 2021 clinical practice guidelines for blood pressure management in patients with CKD

Explore the science
  • February 18, 2022
  • CKD-associated pruritus

Unmet medical needs in patients with CKD-aP: EMJ Nephrology review

Explore the science
  • February 18, 2022
  • Iron Deficiency

Health-related QoL in patients with acute HF

Explore the science
  • February 18, 2022
  • Iron Deficiency

Iron therapy in patients with HF: preclinical data

Explore the science
  • February 18, 2022
  • Iron Deficiency

Iron supplementation in patients with heart failure (HF): how, when, and in which patients

Explore the science